Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants. 2015

Pierre-Emmanuel Bouet, and Stéphanie Brun, and Hugo Madar, and Anne-Laure Baisson, and Véronique Courtay, and Géraldine Gascoin-Lachambre, and Sigismond Lasocki, and Loïc Sentilhes
Department of Obstetrics and Gynecology, Montreal University Hospital-Montreal-Canada.

The aim of our study was to assess the feasibility of implementing a protocol for the use of magnesium sulfate to prevent cerebral palsy. This retrospective single-center study included all women with fetuses of gestational age <33 weeks of gestation whose birth was planned or expected within 24 hours from September 2011 to December 2012. They were to receive magnesium sulfate, administered intravenously as a 4-g bolus followed by a constant infusion of 1 g per hour. If delivery had not occurred after 12 hours and was no longer considered imminent, the infusion was to be discontinued. The study included 119 women, 81 (68.1%) of whom received magnesium sulfate. Among the latter, 71 (87.5%) gave birth within 24 hours. The reasons treatment was not given were: omission by medical team (19/38, 50%), urgent delivery (18/38, 47.4%), and contraindication to treatment (1/38, 2.6%). The mean gestational age at protocol implementation was 29.6 +/- 2.1 weeks. Maternal monitoring, especially at the onset of infusion, appeared suboptimal. No major maternal side effects were observed. Our study shows that implementing a protocol for prevention of cerebral palsy by magnesium sulfate is feasible in a tertiary obstetric center.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D007752 Obstetric Labor, Premature Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE). Preterm Labor,Labor, Premature,Premature Labor,Premature Obstetric Labor,Labor, Premature Obstetric,Labor, Preterm
D008278 Magnesium Sulfate A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083) Magnesium Sulfate, Heptahydrate,Heptahydrate Magnesium Sulfate,Sulfate, Magnesium
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002547 Cerebral Palsy A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7) Diplegic Infantile Cerebral Palsy,Little Disease,Monoplegic Cerebral Palsy,Quadriplegic Infantile Cerebral Palsy,Spastic Diplegia,CP (Cerebral Palsy),Cerebral Palsy, Athetoid,Cerebral Palsy, Atonic,Cerebral Palsy, Congenital,Cerebral Palsy, Diplegic, Infantile,Cerebral Palsy, Dyskinetic,Cerebral Palsy, Dystonic-Rigid,Cerebral Palsy, Hypotonic,Cerebral Palsy, Mixed,Cerebral Palsy, Monoplegic, Infantile,Cerebral Palsy, Quadriplegic, Infantile,Cerebral Palsy, Rolandic Type,Cerebral Palsy, Spastic,Congenital Cerebral Palsy,Diplegia, Spastic,Infantile Cerebral Palsy, Diplegic,Infantile Cerebral Palsy, Monoplegic,Infantile Cerebral Palsy, Quadriplegic,Little's Disease,Monoplegic Infantile Cerebral Palsy,Rolandic Type Cerebral Palsy,Athetoid Cerebral Palsy,Atonic Cerebral Palsy,Cerebral Palsies, Athetoid,Cerebral Palsies, Dyskinetic,Cerebral Palsies, Dystonic-Rigid,Cerebral Palsies, Monoplegic,Cerebral Palsy, Dystonic Rigid,Cerebral Palsy, Monoplegic,Diplegias, Spastic,Dyskinetic Cerebral Palsy,Dystonic-Rigid Cerebral Palsies,Dystonic-Rigid Cerebral Palsy,Hypotonic Cerebral Palsies,Hypotonic Cerebral Palsy,Mixed Cerebral Palsies,Mixed Cerebral Palsy,Monoplegic Cerebral Palsies,Spastic Cerebral Palsies,Spastic Cerebral Palsy,Spastic Diplegias
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages

Related Publications

Pierre-Emmanuel Bouet, and Stéphanie Brun, and Hugo Madar, and Anne-Laure Baisson, and Véronique Courtay, and Géraldine Gascoin-Lachambre, and Sigismond Lasocki, and Loïc Sentilhes
June 2011, Obstetrics and gynecology clinics of North America,
Pierre-Emmanuel Bouet, and Stéphanie Brun, and Hugo Madar, and Anne-Laure Baisson, and Véronique Courtay, and Géraldine Gascoin-Lachambre, and Sigismond Lasocki, and Loïc Sentilhes
August 2008, The New England journal of medicine,
Pierre-Emmanuel Bouet, and Stéphanie Brun, and Hugo Madar, and Anne-Laure Baisson, and Véronique Courtay, and Géraldine Gascoin-Lachambre, and Sigismond Lasocki, and Loïc Sentilhes
December 2016, Journal de gynecologie, obstetrique et biologie de la reproduction,
Pierre-Emmanuel Bouet, and Stéphanie Brun, and Hugo Madar, and Anne-Laure Baisson, and Véronique Courtay, and Géraldine Gascoin-Lachambre, and Sigismond Lasocki, and Loïc Sentilhes
November 2015, Archives of disease in childhood. Fetal and neonatal edition,
Pierre-Emmanuel Bouet, and Stéphanie Brun, and Hugo Madar, and Anne-Laure Baisson, and Véronique Courtay, and Géraldine Gascoin-Lachambre, and Sigismond Lasocki, and Loïc Sentilhes
February 2004, JAMA,
Pierre-Emmanuel Bouet, and Stéphanie Brun, and Hugo Madar, and Anne-Laure Baisson, and Véronique Courtay, and Géraldine Gascoin-Lachambre, and Sigismond Lasocki, and Loïc Sentilhes
February 2004, JAMA,
Pierre-Emmanuel Bouet, and Stéphanie Brun, and Hugo Madar, and Anne-Laure Baisson, and Véronique Courtay, and Géraldine Gascoin-Lachambre, and Sigismond Lasocki, and Loïc Sentilhes
April 2012, Current opinion in pediatrics,
Pierre-Emmanuel Bouet, and Stéphanie Brun, and Hugo Madar, and Anne-Laure Baisson, and Véronique Courtay, and Géraldine Gascoin-Lachambre, and Sigismond Lasocki, and Loïc Sentilhes
October 2011, American journal of obstetrics and gynecology,
Pierre-Emmanuel Bouet, and Stéphanie Brun, and Hugo Madar, and Anne-Laure Baisson, and Véronique Courtay, and Géraldine Gascoin-Lachambre, and Sigismond Lasocki, and Loïc Sentilhes
November 2010, F1000 medicine reports,
Pierre-Emmanuel Bouet, and Stéphanie Brun, and Hugo Madar, and Anne-Laure Baisson, and Véronique Courtay, and Géraldine Gascoin-Lachambre, and Sigismond Lasocki, and Loïc Sentilhes
August 2009, Obstetrics and gynecology,
Copied contents to your clipboard!